filmov
tv
May 9-10, 2023 Joint Meeting of the NDAC and the ORUDAC - Day 1
Показать описание
The committees will discuss a supplemental new drug application (sNDA) 017031/S-041, for OPILL (norgestrel) Tablet, 0.075 mg, submitted by Laboratoire HRA Pharma. OPILL is proposed for nonprescription use as a once daily oral contraceptive to prevent pregnancy.
8:45:19
4:47:55
7:21:56
5:58:54
6:15:00
6:57:45
5:57:33
0:38:56
3:20:59
2:56:12
9:33:56
0:38:47
2:06:13
0:30:28
1:34:20
0:59:58
1:47:01
1:11:15
10:00:19
0:51:46
0:32:22
10:56:22
5:21:56
1:32:33